Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis

201633 citationsJournal Articlebronze Open Access

Authors

This trial was registered with Clinicaltrials.gov as study NCT01759056 and with EudraCT as study 2012-004859-27.

Good health and well-being

Published in: Journal of Crohn s and Colitis

Volume 10, Issue 6, pp. 641-649

Field-Weighted Citation Impact: 3.01